Cheryl Xu bought $21k of SXTP
director at 60 DEGREES PHARMACEUTICALS, INC.. 13,000 shares at an average of $1.65, traded Dec 12, 2024, filed Dec 18, 2024.
Score components
- +15RoleDirector
- 0Trade size$21k at market
- +6Relative to holdingsHoldings up 32%
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -40.0%, 3m -71.2%, 6m -68.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001213900-24-110269, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 12, 2024 | POpen-market purchase Common Stock | +2,500 | $1.85 | $4,625 | 43,578 | Dec 18, 2024 |
| Dec 12, 2024 | POpen-market purchase Common Stock | +2,500 | $1.80 | $4,500 | 46,078 | Dec 18, 2024 |
| Dec 13, 2024 | POpen-market purchase Common Stock | +1,500 | $1.60 | $2,400 | 47,578 | Dec 18, 2024 |
| Dec 13, 2024 | POpen-market purchase Common Stock | +1,500 | $1.58 | $2,370 | 49,078 | Dec 18, 2024 |
| Dec 13, 2024 | POpen-market purchase Common Stock | +1,500 | $1.55 | $2,325 | 50,578 | Dec 18, 2024 |
| Dec 13, 2024 | POpen-market purchase Common Stock | +1,500 | $1.52 | $2,280 | 52,078 | Dec 18, 2024 |
| Dec 16, 2024 | POpen-market purchase Common Stock | +2,000 | $1.45 | $2,900 | 54,078 | Dec 18, 2024 |
Related signals
Other insiders at 60 DEGREES PHARMACEUTICALS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 49Moderate | SXTPbuy 60 DEGREES PHARMACEUTICALS, INC. | Geoffrey S Dow President and CEO | $10k 7,350 shares | +44% | |
| 51Moderate | SXTPbuy 60 DEGREES PHARMACEUTICALS, INC. | Geoffrey S Dow President and CEO | $7,759 9,670 shares | +19% | |
| 49Moderate | SXTPbuy 60 DEGREES PHARMACEUTICALS, INC. | Geoffrey S Dow President and CEO | $12k 12,963 shares | +35% | |
| 29Weak | SXTPbuy 60 DEGREES PHARMACEUTICALS, INC. | Cheryl Xu director | $14k 5,000 shares | +46% | |
| 57Moderate | 60 DEGREES PHARMACEUTICALS, INC. | Geoffrey S Dow President and CEO | $90k 73,951 shares | +358% | |
| 35Weak | SXTPbuy 60 DEGREES PHARMACEUTICALS, INC. | Geoffrey S Dow President and CEO | $6,367 7,000 shares | +51% | |
| 26Weak | SXTPbuy 60 DEGREES PHARMACEUTICALS, INC. | Cheryl Xu director | $8,500 5,000 shares | +14% | |
| 59Moderate | 60 DEGREES PHARMACEUTICALS, INC. | Cheryl Xu director | $75k 200,000 shares | +89% | |
| 46Moderate | 60 DEGREES PHARMACEUTICALS, INC. | Geoffrey S Dow President and CEO | $9,740 25,974 shares | +4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.